148 related articles for article (PubMed ID: 8879537)
1. A highly practical synthesis of the sialyl Lewis X pentasaccharide and an investigation of binding to E-, P-, and L-selectins.
Kiyoi T; Nakai Y; Kondo H; Ishida H; Kiso M; Hasegawa A
Bioorg Med Chem; 1996 Aug; 4(8):1167-76. PubMed ID: 8879537
[TBL] [Abstract][Full Text] [Related]
2. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin.
Stroud MR; Handa K; Salyan ME; Ito K; Levery SB; Hakomori S; Reinhold BB; Reinhold VN
Biochemistry; 1996 Jan; 35(3):770-8. PubMed ID: 8547257
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
[TBL] [Abstract][Full Text] [Related]
4. Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans.
Mare L; Trinchera M
Eur J Biochem; 2004 Jan; 271(1):186-94. PubMed ID: 14686931
[TBL] [Abstract][Full Text] [Related]
5. Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.
Ohmoto H; Nakamura K; Inoue T; Kondo N; Inoue Y; Yoshino K; Kondo H; Ishida H; Kiso M; Hasegawa A
J Med Chem; 1996 Mar; 39(6):1339-43. PubMed ID: 8632441
[TBL] [Abstract][Full Text] [Related]
6. Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.
Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
Biochemistry; 1995 Mar; 34(9):2925-36. PubMed ID: 7534477
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic synthesis of a 6'-sulphated sialyl-Lewisx which is an inhibitor of L-selectin binding to peripheral addressin.
Scudder PR; Shailubhai K; Duffin KL; Streeter PR; Jacob GS
Glycobiology; 1994 Dec; 4(6):929-32. PubMed ID: 7537558
[TBL] [Abstract][Full Text] [Related]
8. A convenient and efficient synthesis of sialyl Lewis X.
Baba K; Iwata N; Hamajima H; Ikami T; Ishida H; Hasegawa A; Kiso M
Biosci Biotechnol Biochem; 1998 Mar; 62(3):590-2. PubMed ID: 9571794
[TBL] [Abstract][Full Text] [Related]
9. 6-O-sulfo sialylparagloboside and sialyl Lewis X neo-glycolipids containing lactamized neuraminic acid: synthesis and antigenic reactivity against G159 monoclonal antibody.
Yamaguchi M; Ishida H; Kanamori A; Kannagi R; Kiso M
Glycoconj J; 2005 Mar; 22(3):95-108. PubMed ID: 16133830
[TBL] [Abstract][Full Text] [Related]
10. Efficient enzymatic synthesis of the sialyl-Lewisx tetrasaccharide. A ligand for selectin-type adhesion molecules.
de Vries T; van den Eijnden DH; Schultz J; O'Neill R
FEBS Lett; 1993 Sep; 330(3):243-8. PubMed ID: 7690713
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
Maaheimo H; Renkonen R; Turunen JP; Penttilä L; Renkonen O
Eur J Biochem; 1995 Dec; 234(2):616-25. PubMed ID: 8536711
[TBL] [Abstract][Full Text] [Related]
12. The 2-naphthylmethyl (NAP) group in carbohydrate synthesis: first total synthesis of the GlyCAM-1 oligosaccharide structures.
Xia J; Alderfer JL; Piskorz CF; Matta KL
Chemistry; 2001 Jan; 7(2):356-67. PubMed ID: 11271521
[TBL] [Abstract][Full Text] [Related]
13. Oligosaccharides derived by keratanase II digestion of bovine articular cartilage keratan sulphates.
Brown GM; Huckerby TN; Nieduszynski IA
Eur J Biochem; 1994 Sep; 224(2):281-308. PubMed ID: 7925342
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.
Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
Biochemistry; 1996 Jul; 35(27):8914-24. PubMed ID: 8688427
[TBL] [Abstract][Full Text] [Related]
15. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.
Nelson RM; Cecconi O; Roberts WG; Aruffo A; Linhardt RJ; Bevilacqua MP
Blood; 1993 Dec; 82(11):3253-8. PubMed ID: 7694675
[TBL] [Abstract][Full Text] [Related]
16. Sulfation of sialyl lactosamine oligosaccharides by chondroitin 6-sulfotransferase.
Habuchi O; Suzuki Y; Fukuta M
Glycobiology; 1997 Apr; 7(3):405-12. PubMed ID: 9147050
[TBL] [Abstract][Full Text] [Related]
17. Structure-function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid and sulphate as a sialic acid replacement.
Brandley BK; Kiso M; Abbas S; Nikrad P; Srivasatava O; Foxall C; Oda Y; Hasegawa A
Glycobiology; 1993 Dec; 3(6):633-41. PubMed ID: 7510548
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic synthesis of site-specifically (alpha 1-3)-fucosylated polylactosamines containing either a sialyl Lewis (x), a VIM-2, or a sialylated and internally difucosylated sequence.
Räbinä J; Natunen J; Niemelä R; Salminen H; Ilves K; Aitio O; Maaheimo H; Helin J; Renkonen O
Carbohydr Res; 1997 Dec; 305(3-4):491-9. PubMed ID: 9648266
[TBL] [Abstract][Full Text] [Related]
19. P- and E-selectins recognize sialyl 6-sulfo Lewis X, the recently identified L-selectin ligand.
Ohmori K; Kanda K; Mitsuoka C; Kanamori A; Kurata-Miura K; Sasaki K; Nishi T; Tamatani T; Kannagi R
Biochem Biophys Res Commun; 2000 Nov; 278(1):90-6. PubMed ID: 11071860
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs.
Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T
Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
